Fig 1.
Percentage (A) and concentration (B) of every lipid class in the KD serum before and after treatment among IVIG-sensitive, -intermediate, and -resistant groups. ** P < 0.01.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.